Videoconferences Close

Advanced topics: Melanoma

Access to Professionals

Exclusive content for professionals

Advanced Topics in Multidisciplinary Cancer Care in Melanoma Online Educational Event.

Melanoma is the most aggressive of the common forms of skin cancer. Although historically the outcomes for patients with melanoma have been very poor, in recent years the treatments and outcomes for this disease have improved dramatically. These advances were based upon an improved understanding of the pathogenesis and heterogeneity of this disease. In particular, this information has been used to develop new immune therapies that are achieving long-term survival in an increasing number of patients, and in a growing number of clinical scenarios. In parallel to these advances, emerging data is suggesting new paradigms for cancer staging, biomarker testing, and surgical management for this disease.

In this educational session we will review recent advances and changes in the care of melanoma patients across the disease continuum. We will also discuss new insights into predictors and mechanisms of resistance to current therapies, which are driving the generation of next-generation treatments. Specific topics to be covered will include:

  • Updates to the Melanoma Staging System and Surgical Approaches For Clinically Localized and Regional Disease.
  • The Role and Rationale for Biomarkers to Guide Patient Care.
  • Regional Disease: New Adjuvant and Neoadjuvant Therapies.
  • Advances in the Treatment of Stage IV Melanoma Patients and the Management of Treatment-Related Toxicities.
  • Emerging Insights Into Resistance and Toxicity from Immunotherapy
10:00 - 10:10 am
(GMT – 6)

Welcome & INTRODUCTION

Michael A. Davies, MD, PhD
Department of Melanoma Medical Oncology,
The University of Texas MD Anderson Cancer Center, Houston, TX.

10:10 - 11:35 am
(GMT – 6)

Updates to the Melanoma Staging System and Surgical Approaches For Clinically Localized and Regional Disease

Jeffrey E. Gershenwald, MD
Department of Surgical Oncology, Division of Surgery,
The University of Texas MD Anderson Cancer Center, Houston, TX.

The Role and Rationale for Biomarkers to Guide Patient Care

Michael T. Tetzlaff, MD, PhD
Department of Pathology, Division of Pathology and Laboratory Medicine,
The University of Texas MD Anderson Cancer Center, Houston, TX.

Regional Disease: New Adjuvant and Neoadjuvant Therapies

Hussein A. Tawbi, MD, PhD
Department of Melanoma Medical Oncology, Division of Cancer Medicine,
The University of Texas MD Anderson Cancer Center, Houston, TX.

Advances in the Treatment of Stage IV Melanoma Patients and the Management of Treatment-Related Toxicities

Michael A. Davies, MD, PhD
Department of Melanoma Medical Oncology,
The University of Texas MD Anderson Cancer Center, Houston, TX.

Emerging Insights Into Resistance and Toxicity from Immunotherapy

Jennifer Wargo, MD, MMSc
Department of Surgical Oncology, Division of Surgery, 
The University of Texas MD Anderson Cancer Center, Houston, TX.

11:35 - 12:00 am
(GMT – 6)

Q&A

12:00 am
(GMT – 6)

Closure

  • Contenidos
    Michael A. Davies
    MD, PhD. Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
    Ver Curriculum Vitae completo
  • Contenidos
    Dr. Rafael Bravo
    Licenciado en Medicina y Cirugía por la Universidad Complutense de Madrid, ha realizado los cursos Doctorado Medicina Interna Universidad Complutense de Madrid y es Master en Información y Documentación por la Universidad Carlos III de Getafe, Madrid. Es Médico especialista en Medicina familiar y comunitaria. Ha trabajado como tal en Centros de Salud del Servicio Madrileño de Salud, primero en el Centro de Salud Las Margaritas, El Greco y Sector III de Getafe y actualmente en el Centro de salud Linneo de Madrid.
    Ver Curriculum Vitae completo
  • Contenidos
    Michael T. Tetzlaff
    MD, PhD. Department of Pathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
    Ver Curriculum Vitae completo
  • Contenidos
    Hussein A. Tawbi
    MD, PhD. Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
    Ver Curriculum Vitae completo
  • Contenidos
    Jennifer Wargo
    MD, MMSc. Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.
    Ver Curriculum Vitae completo

We use our own and third-party cookies to improve our services and show you advertising related to your preferences by analyzing your browsing habits. I have read and expressly accept the Privacy Policy and the Cookies policy.

Aceptar